Stability of microarray patches for transdermal delivery of the nucleoside reverse transcriptase translocation inhibitor Islatravir for HIV treatment

Natalia N. Porfiryeva; Anjali Pandya; Lalitkumar K. Vora; Fabiana Volpe-Zanutto; Akmal  Sabri; Priscilla  Kwarteng; Jessica Mistilis; Robert K.M.  Choy; Ryan F. Donnelly

Stability of microarray patches for transdermal delivery of the nucleoside reverse transcriptase translocation inhibitor Islatravir for HIV treatment

Natalia N. Porfiryeva^*, Anjali Pandya, Lalitkumar K. Vora, Fabiana Volpe-Zanutto, Akmal Sabri, Priscilla Kwarteng, Jessica Mistilis, Robert K.M. Choy, Ryan F. Donnelly

^*Corresponding author for this work

School of Pharmacy

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Abstract

HIV remains a global health challenge, affecting 39 million people worldwide, with the highest prevalence in Africa. Infants under one year old are particularly at risk, underscoring the need for effective and well-tolerated antiretroviral treatments, as well as preventive measures such as pre-exposure prophylaxis (PrEP), which plays a crucial role in HIV prevention strategies.

Original language	English
Title of host publication	5th European Conference on Pharmaceutics: Proceedings
Publisher	European Conference on Pharmaceutics
Number of pages	2
Publication status	Published - 25 Mar 2025
Event	5th European Conference on Pharmaceutics - Porto, Portugal Duration: 24 Mar 2025 → 25 Mar 2025 https://managedreg.crowdcomms.com/5th-european-conference-on-pharmaceutics

Conference

Conference	5th European Conference on Pharmaceutics
Country/Territory	Portugal
City	Porto
Period	24/03/2025 → 25/03/2025
Internet address	https://managedreg.crowdcomms.com/5th-european-conference-on-pharmaceutics

Keywords

microarray patches
transdermal delivery
nucleoside reverse

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://clients.shocklogic.com/ECOP2025/Licence: Unspecified

Cite this

Porfiryeva, N. N., Pandya, A., Vora, L. K., Volpe-Zanutto, F., Sabri, A., Kwarteng, P., Mistilis, J., Choy, R. K. M., & Donnelly, R. F. (2025). Stability of microarray patches for transdermal delivery of the nucleoside reverse transcriptase translocation inhibitor Islatravir for HIV treatment. In 5th European Conference on Pharmaceutics: Proceedings European Conference on Pharmaceutics. https://clients.shocklogic.com/ECOP2025/

@inproceedings{cd6050c46dab4716b88be818408e90ad,

title = "Stability of microarray patches for transdermal delivery of the nucleoside reverse transcriptase translocation inhibitor Islatravir for HIV treatment",

abstract = "HIV remains a global health challenge, affecting 39 million people worldwide, with the highest prevalence in Africa. Infants under one year old are particularly at risk, underscoring the need for effective and well-tolerated antiretroviral treatments, as well as preventive measures such as pre-exposure prophylaxis (PrEP), which plays a crucial role in HIV prevention strategies.",

keywords = "microarray patches, transdermal delivery, nucleoside reverse",

author = "Porfiryeva, {Natalia N.} and Anjali Pandya and Vora, {Lalitkumar K.} and Fabiana Volpe-Zanutto and Akmal Sabri and Priscilla Kwarteng and Jessica Mistilis and Choy, {Robert K.M.} and Donnelly, {Ryan F.}",

year = "2025",

month = mar,

day = "25",

language = "English",

booktitle = "5th European Conference on Pharmaceutics: Proceedings",

publisher = "European Conference on Pharmaceutics",

note = "5th European Conference on Pharmaceutics ; Conference date: 24-03-2025 Through 25-03-2025",

url = "https://managedreg.crowdcomms.com/5th-european-conference-on-pharmaceutics",

}

Porfiryeva, NN , Pandya, A , Vora, LK, Volpe-Zanutto, F, Sabri, A, Kwarteng, P, Mistilis, J, Choy, RKM & Donnelly, RF 2025, Stability of microarray patches for transdermal delivery of the nucleoside reverse transcriptase translocation inhibitor Islatravir for HIV treatment. in 5th European Conference on Pharmaceutics: Proceedings. European Conference on Pharmaceutics, 5th European Conference on Pharmaceutics, Porto, Portugal, 24/03/2025. <https://clients.shocklogic.com/ECOP2025/>

Stability of microarray patches for transdermal delivery of the nucleoside reverse transcriptase translocation inhibitor Islatravir for HIV treatment. / Porfiryeva, Natalia N.; Pandya, Anjali ; Vora, Lalitkumar K. et al.
5th European Conference on Pharmaceutics: Proceedings. European Conference on Pharmaceutics, 2025.

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

TY - GEN

T1 - Stability of microarray patches for transdermal delivery of the nucleoside reverse transcriptase translocation inhibitor Islatravir for HIV treatment

AU - Porfiryeva, Natalia N.

AU - Pandya, Anjali

AU - Vora, Lalitkumar K.

AU - Volpe-Zanutto, Fabiana

AU - Sabri, Akmal

AU - Kwarteng, Priscilla

AU - Mistilis, Jessica

AU - Choy, Robert K.M.

AU - Donnelly, Ryan F.

PY - 2025/3/25

Y1 - 2025/3/25

N2 - HIV remains a global health challenge, affecting 39 million people worldwide, with the highest prevalence in Africa. Infants under one year old are particularly at risk, underscoring the need for effective and well-tolerated antiretroviral treatments, as well as preventive measures such as pre-exposure prophylaxis (PrEP), which plays a crucial role in HIV prevention strategies.

AB - HIV remains a global health challenge, affecting 39 million people worldwide, with the highest prevalence in Africa. Infants under one year old are particularly at risk, underscoring the need for effective and well-tolerated antiretroviral treatments, as well as preventive measures such as pre-exposure prophylaxis (PrEP), which plays a crucial role in HIV prevention strategies.

KW - microarray patches

KW - transdermal delivery

KW - nucleoside reverse

M3 - Conference contribution

BT - 5th European Conference on Pharmaceutics: Proceedings

PB - European Conference on Pharmaceutics

T2 - 5th European Conference on Pharmaceutics

Y2 - 24 March 2025 through 25 March 2025

ER -

Stability of microarray patches for transdermal delivery of the nucleoside reverse transcriptase translocation inhibitor Islatravir for HIV treatment

Abstract

Conference

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this